Skip to content

EBIT at other companies

CTO
Citius Oncology, Inc.CTOR
-$28.61M-283%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$11.44M+27.5%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
-$9.36M-512%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Gilead Sciences logo
Gilead SciencesGILD
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue-
Operating income-$5.2M+6.8%
Net income-$5.8M-6.1%
EPS (diluted)-$0.19+24.0%

Balance sheet

See full
Cash & equivalents$4.4M-40.2%
Total debt$48.0K0.0%
Total equity$6.9M-63.0%
Total assets$26.3M-54.4%

Cash flow

See full
Operating cash flow-$3.4M+44.6%
CapEx-
Free cash flow-$6.3M

Valuation

See full
Market cap$88.96M+164%

Returns & leverage

See full
Return on equity-123.3%+86.1pp
Debt / equity0.0×
Current ratio0.4×-1.0×

Where this comes from

Calculated from RNTX’s reported figures.

The official record: RNTX’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about RNTX's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RNTX's EBIT?
RNTX (RNTX) reported EBIT of -$5.23M in Q1 2026.
How has RNTX's EBIT changed year-over-year?
RNTX's EBIT increased by 6.8% year-over-year, from -$5.61M to -$5.23M.
What is the long-term trend for RNTX's EBIT?
Over 4 years (2021 to 2025), RNTX's EBIT has grown at a 17.5% compound annual growth rate (CAGR), from -$26.61M to -$50.63M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.